Ropivacaine
Pronunciation: (ROH-pee va-KAYN).
- Generic name
- Ropivacaine
- Brand names
- Ropivacaine Injection, Ropivacaine, Ropivacaine Pfizer, Ropivacaine B. Braun, Ropicaine, Ropivacaine Accord
- Drug class
- Local anesthetic (amide type)
Availability and supply rules vary by country
Trade names by country: United States · Canada
Australia: · Full directory
What Ropivacaine is and how it works
Uses, formulations, monitoring, and supply rules can differ by patient, product, and country. Follow the exact local product information and professional advice.
Mechanism of action: how Ropivacaine works
Ropi vacaine (ropivacaine) is an amide-type local anesthetic that blocks voltage-gated sodium channels in neuronal cell membranes. This inhibition prevents the initiation and propagation of nerve impulses, resulting in reversible loss of sensation and, at higher concentrations, motor function in the targeted area. (1)
What Ropivacaine is used for
Local anesthesia for surgical procedures
Local anesthesia for surgical procedures (1)
Regional anesthesia for surgical procedures (e.g., epidural, nerve block)
Regional anesthesia for surgical procedures (e.g., epidural, nerve block) (1)
Acute pain management (e.g., postoperative pain, labor pain)
Acute pain management (e.g., postoperative pain, labor pain) (1)
Chronic pain management (e.g., nerve blocks for neuropathic pain)
Chronic pain management (e.g., nerve blocks for neuropathic pain) (1)
Before taking Ropivacaine
Do not take / not appropriate for
- Contraindicated in patients with known hypersensitivity to amide-type anesthetics, severe hypotension, or advanced heart block without a pacemaker. (Contraindication) (1)
Tell your clinician about
(1)How to take Ropivacaine
- General Instructions: Ropi vacaine is administered by a healthcare professional in a clinical setting. Do not self-administer.. Adult Dosing: Typical doses vary based on the procedure and route (e.g., 1-2 mg/mL for epidural anesthesia; total dose and concentration adjusted by the provider).. Pediatric Dosing: Dosing in children is weight-based and determined by the healthcare provider. Safety and efficacy should be carefully monitored.. Administration: Given as an injection near nerves, into tissue, or into the epidural space. The area will be monitored for numbness and side effects.. When To Stop: The medication is stopped after the procedure or when pain control is no longer needed. Notify your provider if you experience side effects.. Storage: Store vials at room temperature, away from light and moisture. Do not freeze. Keep out of reach of children.
- This page does not provide a dose calculator. Dosing must follow the prescriber, pharmacist, or product label.
Procedures and treatment changes
Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1)
Missed dose
Since ropi vacaine is given by a healthcare professional as needed for procedures or pain control, missed doses are unlikely. If you have concerns about pain control, notify your provider.
Overdose
Symptoms of overdose may include seizures, irregular heartbeat, respiratory depression, or cardiac arrest. Seek emergency medical help immediately if overdose is suspected. (1)
Side effects
Side effects and their urgency vary; report severe, persistent, or concerning symptoms to a healthcare professional.
Nausea
Incidence: Reported in the clinician-authored database; frequency not established
Vomiting
Incidence: Reported in the clinician-authored database; frequency not established
Bradycardia
Incidence: Reported in the clinician-authored database; frequency not established
Hypotension
Incidence: Reported in the clinician-authored database; frequency not established
Dizziness
Incidence: Reported in the clinician-authored database; frequency not established
Seizures
Incidence: Reported in the clinician-authored database; frequency not established
Cardiac arrest
Incidence: Reported in the clinician-authored database; frequency not established
Allergic reactions
Incidence: Reported in the clinician-authored database; frequency not established
Serious warnings
Only to be administered by trained healthcare professionals — serious
Symptoms: Only to be administered by trained healthcare professionals. May cause temporary loss of sensation or movement. Risk of systemic toxicity if injected into blood vessels. Use caution in patients with liver, kidney, or heart disease. Monitor for allergic reactions and neurological symptoms.
Action: Follow the urgency stated and seek prompt or emergency care when indicated. (1)
Contraindications recorded in the clinician database — serious
Symptoms: Contraindications recorded in the clinician database: Contraindicated in patients with known hypersensitivity to amide-type anesthetics, severe hypotension, or advanced heart block without a pacemaker. Use caution in patients with hepatic or renal impairment, elderly, pregnant or breastfeeding women, and those with cardiovascular disease.
Action: Follow the urgency stated and seek prompt or emergency care when indicated. (1)
Interactions
| Medicine or test | Effect | Action |
|---|---|---|
| Recorded interactions | Ropi vacaine may interact with other local anesthetics, antiarrhythmic drugs (e.g., amiodarone, lidocaine), and certain antidepressants. Inform your provider about all medications and supplements you are taking to avoid potential interactions. | (1) |
Pregnancy, breastfeeding, kidney/liver function, age
Pregnancy
Ropivacaine is used in obstetric epidural anesthesia (e.g., for labor pain and cesarean section) under direct medical supervision per its approved indications; use outside these indicated obstetric settings during pregnancy should be directed by the treating anesthesiologist. (1)
Breastfeeding
The FDA label does not provide specific human lactation data for ropivacaine; as with other local anesthetics used for regional anesthesia, breastfeeding timing after a procedure should be discussed with the treating clinician. (1)
Children
Frequency: Dosing frequency for children is every 4-6 hours as needed.. Weight Based: Weight-based dosing is typically 0.5-1 mg/kg/dose for children.. Max Daily Dose: Maximum daily dose for children should not exceed 5 mg/kg.. Max Single Dose: Maximum single dose for children is 2.5 mg/kg, not to exceed 20 mg.. Age Restrictions: Safety not established in children under 12 years of age. (1)
Renal_impairment
Renal impairment: care in dose selection is advised, starting at the low end of the dosing range, since ropivacaine and its metabolites are renally excreted; no fixed numeric adjustment table is given. Hepatic impairment: because ropivacaine (an amide-type local anesthetic) is metabolized by the liver, it — and especially repeated doses — should be used cautiously in patients with hepatic disease, who are at greater risk of toxic plasma concentrations due to reduced metabolism; specific numeric dose-reduction figures are not provided in the label. (1)
Hepatic_impairment
Renal impairment: care in dose selection is advised, starting at the low end of the dosing range, since ropivacaine and its metabolites are renally excreted; no fixed numeric adjustment table is given. Hepatic impairment: because ropivacaine (an amide-type local anesthetic) is metabolized by the liver, it — and especially repeated doses — should be used cautiously in patients with hepatic disease, who are at greater risk of toxic plasma concentrations due to reduced metabolism; specific numeric dose-reduction figures are not provided in the label. (1)
Monitoring
(1)Storage
Store at 20-25°C (68-77°F); do not freeze. Protect from light where specified on the product carton; administered only by a healthcare professional trained in regional anesthesia, per the FDA label.
Professional information
Clinician-facing context only. This section does not replace current product labeling.
General
Indication: Local anesthesia for surgical procedures
Dose summary: The standard dosing for Ropivacaine is typically 5-15 mg for infiltration anesthesia.
Renal context: Ropivacaine and its metabolites are excreted by the kidney. The FDA label for NAROPIN advises care in dose selection and recommends starting at the low end of the dosing range in patients with impaired renal function, reflecting the greater frequency of decreased renal function seen with age and comorbidity; no fixed numeric dose-reduction table is given. (1)
Frequently asked questions
How long does the numbness from ropi vacaine last?
The duration of numbness depends on the dose and site of administration, but effects typically last 2 to 8 hours. Some pain relief may persist longer after the procedure.
Can I receive ropi vacaine if I am pregnant?
Ropi vacaine is sometimes used for epidural anesthesia during labor. Your doctor will weigh the benefits and risks before administration.
What should I do if I feel dizzy or have ringing in my ears after the injection?
Notify your healthcare provider immediately, as these may be early signs of systemic toxicity.
Is ropi vacaine safe for children?
Ropi vacaine can be used in children for certain procedures, but dosing is carefully adjusted based on weight and age.
Can I take other pain medications with ropi vacaine?
Your doctor may prescribe additional pain medications if needed. Always inform your provider about all medicines you are taking to avoid interactions.
What are the signs of an allergic reaction to ropi vacaine?
Signs include rash, itching, swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing. Seek emergency help if these occur.
How is ropi vacaine different from bupivacaine?
Ropi vacaine has a similar anesthetic effect but is associated with a lower risk of heart and central nervous system side effects compared to bupivacaine.
What happens if I take too much Ropivacaine?
Taking too much Ropivacaine can lead to serious side effects, including central nervous system toxicity (e.g., seizures, dizziness, ringing in the ears) and cardiovascular issues (e.g., irregular heartbeat, low blood pressure). If you suspect an overdose, seek immediate emergency medical attention. Prompt treatment is crucial to manage these potentially life-threatening complications.
Can I drink alcohol while taking Ropivacaine?
It is generally advisable to avoid alcohol while receiving Ropivacaine. Alcohol can exacerbate the central nervous system depressant effects of local anesthetics, potentially leading to increased drowsiness, dizziness, and impaired coordination. Additionally, alcohol can affect blood pressure, which may interfere with the cardiovascular effects of Ropivacaine. Always consult your healthcare provider for personalized advice.
Is Ropivacaine safe during pregnancy?
The safety of Ropivacaine during pregnancy requires careful consideration. It is categorized as a Pregnancy Category C drug, meaning animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans. Therefore, Ropivacaine should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Always consult your doctor to discuss the risks and benefits.
What is the mechanism of action of Ropivacaine?
Ropi vacaine (ropivacaine) is an amide-type local anesthetic that blocks voltage-gated sodium channels in neuronal cell membranes. This inhibition prevents the initiation and propagation of nerve impulses, resulting in reversible loss of sensation and, at higher concentrations, motor function in the targeted area. (1)
What is the generic name of Ropivacaine?
The generic name is Ropivacaine. It is sold under brand names including Ropivacaine Injection, Ropivacaine, Ropivacaine Pfizer, Ropivacaine B. Braun, Ropicaine, Ropivacaine Accord.
What class of drug is Ropivacaine?
Ropivacaine is classed as: Local anesthetic (amide type).
References
- Ropi vacaine — Prescribing InformationMedGuideGlobal · United States · accessed 2026-08-03 · source 1
- NAROPIN (ropivacaine hydrochloride) — FDA-approved prescribing informationU.S. National Library of Medicine (DailyMed) · United States · accessed 2026-08-07 · source 2
- ROPIVACAINE HYDROCHLORIDE — FDA approval record (Drugs@FDA ANDA219883)U.S. Food and Drug Administration · US · accessed 2026-08-14 · source 3
- Ropivacaine — RxNorm normalized drug concept (RXCUI 1298851)U.S. National Library of Medicine (RxNorm) · US · accessed 2026-08-14 · source 4
Brand names by country
Single-ingredient Ropivacaine names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Naropin2 mg/mL, 10 mg/mL, 5 mg/mL, 7.5 mg/mL · fresenius kabi usa, llc
Canada
- NAROPIN INJ